HIV and AIDS(Human Immunodeficiency Virus and Acquired Immunodeficiency Syndrome)
by
Rick Alan DefinitionHIV is a virus that attacks white blood cells called helper T cells (CD4). These cells are part of the immune system. They fight off infections and disease. As a result, an HIV infection can leave you vulnerable to severe illnesses. AIDS is a late stage of HIV infection. It reflects severe damage to the immune system. One or more opportunistic infections will also likely exist. This is a type of infection that only occurs in people with compromised immune systems. CausesThe HIV virus is spread through contact with HIV-infected blood or other body fluids. This includes semen, vaginal fluid, and breast milk. AIDS is caused by the destruction of T cells. The destruction is caused by the HIV virus.
HIV is spread through:
Rarely, HIV can be spread through:
Risk Factors TOPFactors that increase your chance of getting HIV include:
The risk factor for AIDS is having HIV. Symptoms TOPHIV may not cause symptoms for a number of years. Early symptoms may appear a month or two after becoming infected. They may last a couple of weeks. These include:
After these initial symptoms pass, there may be no symptoms for months to years. Then, the following symptoms may occur over the course of 1-3 years:
It can be 10 years or more before HIV progresses to AIDS. This happens when T helper cell levels fall below certain levels and opportunistic infections arise. Examples of opportunistic infections and other complications of AIDS include:
Diagnosis TOPThe doctor will ask about your symptoms, medical history, and risk factors. A physical exam will be done. Your doctor may order tests, such as:
Treatment TOPMedicines can prevent, delay, or control the development of AIDS in many people infected with HIV. Drugs That Fight HIVThese drugs are often given in combination. They include: Nucleoside reverse transcriptase inhibitors:
Nucleotide reverse transcriptase inhibitors:
Protease inhibitors:
Combination pill:
Others:
Drugs That Fight AIDS-Related Infections and CancersPeople who have developed AIDS are treated with numerous drugs that help prevent:
Prevention TOPTo prevent becoming infected with HIV:
Recent studies found that circumcised men were significantly less likely to develop HIV infection compared to uncircumcised men. To prevent spreading HIV to others if you are HIV infected:
RESOURCES:American Foundation for AIDS Research http://www.amfar.org Centers for Disease Control and Prevention http://www.cdc.gov/nchstp/od/nchstp.html CANADIAN RESOURCES:AIDS Committee of Toronto http://www.actoronto.org Canadian AIDS Society http://www.cdnaids.ca References:
Adult male circumcision significantly reduces risk of acquiring HIV [press release]. National Institutes of Health website. Available at:
http://www3.niaid.nih.gov/news/newsreleases/2006/AMC12_06.htm.
Accessed June 13, 2008.
AIDS Info. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. AIDS Info website. Available at:
http://aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL.pdf. Accessed August 9, 2010.
Berkow R.
The Merck Manual of Medical Information. New York, NY: Simon and Schuster, Inc.; 2000.
Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines, 2010.
MMWR.
2010;59(No. RR-12):1-110.
HIV/AIDS A-Z index.
Centers for Disease Control and Prevention website. Available at:
http://www.cdc.gov/hiv/az.htm.
Accessed June 13, 2008.
Montaner JS. Treatment as prevention: a double hat-trick.
Lancet. 2011 Jul 16;378(9787):208-209.
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Centers for Disease Control and Prevention website. Available at:
http://www.cdc.gov/nchstp/od/nchstp.html.
Accessed June 13, 2008.
Rey D, Krebs M, Partisani M, Hess G, et al. Virologic response of zidovudine, lamivudine, and tenofovir disoproxil fumarate combination in antiretroviral-naive HIV-1-infected patients.
J Acquir Immune Defic Syndr. 2006;43: 530-534.
Ross LL, Parkin N, Gerondelis P, et al. Differential impact of thymidine analogue mutations on emtricitabine and lamivudine susceptibility.
J Acquir Immune Defic Syndr. 2006;43(5):567-570.
3/8/2007 DynaMed's Systematic Literature Surveillance
https://dynamed.ebscohost.com/about/about-us: Auvert B, Taljaard D, Lagard E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial.
PLoS Med.
2005;2(11):e298. Epub Oct 25, 2005.
Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007 Feb 24;369(9562):643-656. Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007 Feb 24;369(9562):657-666.
2/21/2008 DynaMed's Systematic Literature Surveillance
https://dynamed.ebscohost.com/about/about-us: Mallal S, Phillips E, Carosi G, et al. HLA-B5701 screening for hypersensitivity to abacavir.
N Engl J Med.
2008;358:568-579.
6/11/2010 DynaMed's Systematic Literature Surveillance
https://dynamed.ebscohost.com/about/about-us: Del Romero J, Castilla J, Hernando V, Rodríguez C, García S. Combined antiretroviral treatment and heterosexual transmission of HIV-1: cross sectional and prospective cohort study.
BMJ.
2010:c2205.
Last reviewed [Under Medical Review] by Lawrence Frisch, MD, MPH Last Updated: 9/20/2011 | |